Structure-toxicity relationship of phenolic analogs as anti-melanoma agents: an enzyme directed prodrug approach.

[1]  K. Srivenugopal,et al.  Efficacy of acetaminophen in skin B16-F0 melanoma tumor-bearing C57BL/6 mice. , 2009, International journal of oncology.

[2]  G. Yount,et al.  Biochemical mechanism of acetaminophen (APAP) induced toxicity in melanoma cell lines. , 2009, Journal of pharmaceutical sciences.

[3]  G. Yount,et al.  Biochemical mechanism of acetylsalicylic acid (Aspirin) selective toxicity toward melanoma cell lines , 2008, Melanoma research.

[4]  J. Bosman,et al.  Aspirin Sensitizes Cancer Cells to TRAIL–Induced Apoptosis by Reducing Survivin Levels , 2008, Clinical Cancer Research.

[5]  R. Mehvar,et al.  Metabolic bioactivation and toxicity of ethyl 4-hydroxybenzoate in human SK-MEL-28 melanoma cells. , 2008, Journal of pharmaceutical sciences.

[6]  I. Ojima.  Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads. , 2008, Accounts of chemical research.

[7]  M. Moridani.  Biochemical basis of 4-hydroxyanisole induced cell toxicity towards B16-F0 melanoma cells. , 2006, Cancer letters.

[8]  R. Mehvar,et al.  Rapid determination of reduced and oxidized glutathione levels using a new thiol-masking reagent and the enzymatic recycling method: application to the rat liver and bile samples , 2006, Analytical and bioanalytical chemistry.

[9]  M. Moridani,et al.  Structural toxicity relationship of 4-alkoxyphenols' cytotoxicity towards murine B16-F0 melanoma cell line. , 2005, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[10]  A. Siraki,et al.  Application of quantitative structure-toxicity relationships for the comparison of the cytotoxicity of 14 p-benzoquinone congeners in primary cultured rat hepatocytes versus PC12 cells. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  Qiang Xu,et al.  Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. , 2004, The American journal of pathology.

[12]  W. Schlage,et al.  Melanogenesis in genetically determined pigment cell tumors of platyfish and platyfish-swordtail hybrids: correlation between tyrosinase activity and degree of malignancy , 1977, Zeitschrift für Krebsforschung und Klinische Onkologie.

[13]  A. Siraki,et al.  Quantitative structure toxicity relationships for phenols in isolated rat hepatocytes. , 2003, Chemico-biological interactions.

[14]  Sumsullah Khan,et al.  Metabolic activation of 3-hydroxyanisole by isolated rat hepatocytes. , 2003, Chemico-biological interactions.

[15]  B. Kasraee.  Peroxidase-Mediated Mechanisms Are Involved in the Melanocytotoxic and Melanogenesis-Inhibiting Effects of Chemical Agents , 2002, Dermatology.

[16]  P. O'Brien,et al.  Metabolic activation of 4-hydroxyanisole by isolated rat hepatocytes. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[17]  T. Yamashita,et al.  Tyrosinase and tyrosinase-related protein 1 require Rab7 for their intracellular transport. , 2002, The Journal of investigative dermatology.

[18]  A. Photiou,et al.  Melanocyte-Directed enzyme prodrug therapy (MDEPT): development of second generation prodrugs for targeted treatment of malignant melanoma. , 2001, Bioorganic & medicinal chemistry.

[19]  I. E. Johansen.  Intron insertion facilitates amplification of cloned virus cDNA in Escherichia coli while biological activity is reestablished after transcription in vivo. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Buzaid,et al.  Systemic treatments for advanced cutaneous melanoma. , 1995, Oncology.

[21]  N. Smit,et al.  Cytotoxicity of a selected series of substituted phenols towards cultured melanoma cells , 1992, Melanoma research.

[22]  P. Philip,et al.  Phase I study of intravenous 4-hydroxyanisole. , 1992, European journal of cancer.

[23]  C. Cooksey,et al.  In vitro assessment of the structure – activity relationship of tyrosinase‐dependent cytotoxicity of a series of substituted phenols , 1991, Melanoma research.

[24]  C. Cooksey,et al.  Initial mushroom tyrosinase-catalysed oxidation product of 4-hydroxyanisole is 4-methoxy-ortho-benzoquinone. , 1988, Pigment cell research.

[25]  C. Cooksey,et al.  Major primary cytotoxic product of 4-hydroxyanisole oxidation by mushroom tyrosinase is 4-methoxy ortho benzoquinone. , 1988, Pigment cell research.

[26]  S. Passi,et al.  Molecular basis of substrate and inhibitory specificity of tyrosinase: phenolic compounds , 1981, The British journal of dermatology.

[27]  W. Chavin,et al.  Tyrosinase Activity in a Highly Pigmented Human Melanoma and in Negro Skin 1 , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[28]  P. A. Riley.  Hydroxyanisole depigmentation: In‐vitro studies , 1969, The Journal of pathology.

[29]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.